What is Aidoc?
Established in early 2016, Aidoc pioneers clinical AI solutions designed to empower healthcare teams and optimize patient treatment, thereby improving both economic value and clinical outcomes. Leveraging its proprietary aiOS, Aidoc analyzes and aggregates medical data, enabling care teams to proactively manage unexpected situations and maintain a patient-centric workflow. The AI operates continuously in the background, transforming foreground clinical processes.
How much funding has Aidoc raised?
Aidoc has raised a total of $570M across 7 funding rounds:
Series A
$7M
Series B
$47M
Series C
$66M
Series D
$110M
Debt
$40M
Other Financing Round
$150M
Series E
$150M
Series A (2017): $7M with participation from Magma Ventures, Emerge, and TLV Partners
Series B (2020): $47M, investors not publicly disclosed
Series C (2021): $66M supported by General Catalyst
Series D (2022): $110M featuring CDIB Capital International, Alpha Intelligence Capital, and The TCV
Debt (2025): $40M, investors not publicly disclosed
Other Financing Round (2025): $150M with participation from SquarePeg, WellSpan Health, NVIDIA, Mercy, Hartford HealthCare, NVentures, Sutter Health, and General Catalyst
Series E (2026): $150M led by General Catalyst, nVentures, Goldman Sachs, and Softbank Vision Fund
Key Investors in Aidoc
General Catalyst
General Catalyst is a venture capital firm that supports transformational business opportunities across various sectors and stages, focusing on backing entrepreneurs with ambitious visions to reshape industries.
CDIB Capital International
CDIB Capital is a leading Asian private equity investor specializing in middle-market growth capital and buyout transactions, with a focus on companies in consumer/retail, manufacturing, healthcare, and technology.
Alpha Intelligence Capital
Alpha Intelligence Capital is a global venture capital firm that invests in AI-first companies, particularly those utilizing deep Artificial Intelligence and Machine Learning technologies to address business challenges.
What's next for Aidoc?
With its latest major strategic investment, Aidoc is poised for accelerated growth and further innovation in the clinical AI space. The company's trajectory suggests a focus on expanding its technological capabilities, deepening its market penetration, and potentially exploring new applications for its AI platform within the healthcare ecosystem. This strategic financing will likely fuel research and development, enhance operational scaling, and solidify Aidoc's position as a key player in the digital health transformation.
See full Aidoc company page
